A new law approved by a state in Brazil's Amazon region will requirenon-Brazilian research groups to work with Brazilian scientists; they will also need special permits.
The law, written by a Brazilian Communist party legislator and passed by Acre's assembly, will also try to guarantee royalties for native Indian communities in exchange for information on rainforest plant life. It is claimed that one non-governmental organization traded painkillers with six Indian tribes in the state for species of plants with medicinal properties, and then sold the plants to international pharmaceutical companies.
Government officials feel foreign researchers do not register genetic discoveries made in the Amazon region and other parts of Brazil to avoid paying royalties and other taxes, it was noted.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze